repurposed recombinant human deoxyribonuclease I enzyme (VBI Vaccines)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namerepurposed recombinant human deoxyribonuclease I enzyme (VBI Vaccines)

Drug Alias NameS-graftrepurposed recombinant human deoxyribonuclease I enzyme (SciVac Therapeutics)

ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme

Mechanisms of ActionDeoxyribonuclease 1 modulators

TargetsDeoxyribonuclease 1

Therapy Area/IndicationsGraft vs Host Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryIsrael

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesVbi Vaccines Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesVbi Vaccines Inc

Active IndicationsN/A

Inactive IndicationsGraft vs Host Disease

ATC CodeN/A